ADMINISTRATION SITE INDENTATION

ADMINISTRATION SITE INDENTATION was reported 62 times

These drug classes are most commonly taken by patients reporting ADMINISTRATION SITE INDENTATION:

# Drug Count
0 PCSK9 Inhibitor [EPC] 13
1 Copper-containing Intrauterine Device [EPC] 11
2 Acetylcholine Release Inhibitor [EPC] 4
3 Neuromuscular Blocker [EPC] 4
4 Progestin [EPC] 4
5 Aldosterone Antagonist [EPC] 2
6 Corticosteroid [EPC] 2
7 Estrogen [EPC] 2
8 Interleukin-23 Antagonist [EPC] 2
9 Opioid Agonist [EPC] 2
10 Proton Pump Inhibitor [EPC] 2
11 Tumor Necrosis Factor Blocker [EPC] 2
12 Amide Local Anesthetic [EPC] 1
13 Aminosalicylate [EPC] 1
14 Angiotensin 2 Receptor Blocker [EPC] 1
15 Antiarrhythmic [EPC] 1
16 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
17 Aromatic Amino Acid [EPC] 1
18 Calcium [EPC] 1
19 Endothelin Receptor Antagonist [EPC] 1
20 Ester Local Anesthetic [EPC] 1
21 Folate Analog Metabolic Inhibitor [EPC] 1
22 Histamine-1 Receptor Antagonist [EPC] 1
23 Histamine-2 Receptor Antagonist [EPC] 1
24 Human Immunoglobulin G [EPC] 1
25 Interleukin-12 Antagonist [EPC] 1
26 Interleukin-17A Antagonist [EPC] 1
27 Loop Diuretic [EPC] 1
28 Non-Standardized Chemical Allergen [EPC] 1
29 Nonsteroidal Anti-inflammatory Drug [EPC] 1
30 Osmotic Laxative [EPC] 1
31 P2Y12 Platelet Inhibitor [EPC] 1
32 Phosphodiesterase 5 Inhibitor [EPC] 1
33 Potassium Channel Blocker [EPC] 1
34 Progestin-containing Intrauterine System [EPC] 1
35 Prostacycline Vasodilator [EPC] 1
36 Provitamin D2 Compound [EPC] 1
37 Serotonin-3 Receptor Antagonist [EPC] 1
38 Thalidomide Analog [EPC] 1
39 Vitamin B12 [EPC] 1
40 Vitamin C [EPC] 1
41 Vitamin D [EPC] 1